Rabin Niroula

444 total citations
23 papers, 284 citations indexed

About

Rabin Niroula is a scholar working on Hematology, Genetics and Oncology. According to data from OpenAlex, Rabin Niroula has authored 23 papers receiving a total of 284 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Hematology, 6 papers in Genetics and 6 papers in Oncology. Recurrent topics in Rabin Niroula's work include Acute Myeloid Leukemia Research (5 papers), Lymphoma Diagnosis and Treatment (5 papers) and Palliative Care and End-of-Life Issues (3 papers). Rabin Niroula is often cited by papers focused on Acute Myeloid Leukemia Research (5 papers), Lymphoma Diagnosis and Treatment (5 papers) and Palliative Care and End-of-Life Issues (3 papers). Rabin Niroula collaborates with scholars based in United States, Nepal and United Kingdom. Rabin Niroula's co-authors include Ari Pelcovits, John L. Reagan, Pamela Egan, Adam J. Olszewski, Thomas Ollila, Fred J. Schiffman, Adam Zayac, İlyas Şahin, Brianna R. Bakow and James N. Butera and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Cancer.

In The Last Decade

Rabin Niroula

21 papers receiving 282 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Rabin Niroula United States 6 120 119 58 44 43 23 284
Lidija Dokmanović Serbia 13 114 0.9× 145 1.2× 88 1.5× 61 1.4× 53 1.2× 47 419
Takanobu Morishita Japan 11 100 0.8× 107 0.9× 70 1.2× 43 1.0× 30 0.7× 37 268
Waleed Sabry Canada 10 143 1.2× 93 0.8× 98 1.7× 21 0.5× 22 0.5× 23 266
Min‐Yuan Wu China 11 176 1.5× 173 1.5× 65 1.1× 20 0.5× 69 1.6× 41 434
Eiju Negoro Japan 11 107 0.9× 136 1.1× 79 1.4× 40 0.9× 9 0.2× 39 318
Manuela Rizzo Italy 7 186 1.6× 133 1.1× 110 1.9× 68 1.5× 36 0.8× 28 378
Wanling Sun China 8 128 1.1× 80 0.7× 37 0.6× 50 1.1× 21 0.5× 41 297
Amandeep Godara United States 8 60 0.5× 137 1.2× 86 1.5× 31 0.7× 13 0.3× 50 259
Raoul Santiago Canada 8 56 0.5× 57 0.5× 59 1.0× 53 1.2× 25 0.6× 22 254
Amr Hanbali United States 9 104 0.9× 108 0.9× 74 1.3× 28 0.6× 67 1.6× 43 301

Countries citing papers authored by Rabin Niroula

Since Specialization
Citations

This map shows the geographic impact of Rabin Niroula's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rabin Niroula with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rabin Niroula more than expected).

Fields of papers citing papers by Rabin Niroula

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Rabin Niroula. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rabin Niroula. The network helps show where Rabin Niroula may publish in the future.

Co-authorship network of co-authors of Rabin Niroula

This figure shows the co-authorship network connecting the top 25 collaborators of Rabin Niroula. A scholar is included among the top collaborators of Rabin Niroula based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Rabin Niroula. Rabin Niroula is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Fathi, Amir T., Aleksandra Filipović, Dale Schaar, et al.. (2024). A Phase I Dose Escalation and Expansion Trial of Lyt-200 (a First-In-Class Anti-Galectin-9 Antibody) Alone and in Combination with Venetoclax/HMA in Relapsed/Refractory AML/MDS. Blood. 144(Supplement 1). 1499–1499. 3 indexed citations
2.
Egan, Pamela, Ari Pelcovits, S. E. Donnelly, et al.. (2023). Removing Transfusion Dependence As a Barrier to Hospice Enrollment (BRUOG-407). Blood. 142(Supplement 1). 259–259.
3.
Yang, Andrew, et al.. (2022). Objective Impact of Hematology-Oncology Hospitalist Care in an Inpatient Setting. JCO Oncology Practice. 18(10). e1641–e1647. 3 indexed citations
4.
Ollila, Thomas, John L. Reagan, Shaolei Lu, et al.. (2022). Seroconversion and outcomes after initial and booster COVID‐19 vaccination in adults with hematologic malignancies. Cancer. 128(18). 3319–3329. 29 indexed citations
5.
Pelcovits, Ari, et al.. (2021). Tumor lysis syndrome risk in outpatient versus inpatient administration of venetoclax and hypomethlators for acute myeloid leukemia. Supportive Care in Cancer. 29(9). 5323–5327. 15 indexed citations
6.
Pelcovits, Ari, Fred J. Schiffman, & Rabin Niroula. (2021). Factor XIII Deficiency. Hematology/Oncology Clinics of North America. 35(6). 1171–1180. 12 indexed citations
7.
Olszewski, Adam J., Anna Chorzalska, Thomas Ollila, et al.. (2021). Detection of clonotypic DNA in the cerebrospinal fluid as a marker of central nervous system invasion in lymphoma. Blood Advances. 5(24). 5525–5535. 24 indexed citations
8.
Sadler, Brooke, Anna Chorzalska, Dennis M. Bonal, et al.. (2021). Whole Genome Sequencing Identifies a Recurrent Mutation in Complement Factor I (CFI) in Primary Myelofibrosis (PMF). Blood. 138(Supplement 1). 1472–1472. 2 indexed citations
9.
Ollila, Thomas, John L. Reagan, Shaolei Lu, et al.. (2021). Factors Associated with Seroconversion after COVID-19 Vaccination in Patients with Hematologic Malignancies. Blood. 138(Supplement 1). 3511–3511. 1 indexed citations
10.
Olszewski, Adam J., Anna Chorzalska, Thomas Ollila, et al.. (2020). Cerebrospinal Fluid (CSF) Analysis of Tumor-Specific Cell-Free DNA (cfDNA) As a Diagnostic and Prognostic Tool for Central Nervous System (CNS) Invasion in Lymphoma. Blood. 136(Supplement 1). 21–22. 5 indexed citations
11.
Niroula, Rabin, et al.. (2020). Patterns Of Psychiatric Referrals In A Tertiary Hospital. 9(2). 48–52. 1 indexed citations
12.
Pelcovits, Ari & Rabin Niroula. (2020). Acute Myeloid Leukemia: A Review.. PubMed. 103(3). 38–40. 167 indexed citations
13.
Olszewski, Adam J., Anna Chorzalska, Diana O. Treaba, et al.. (2019). Tumor-Specific Cell-Free DNA (cfDNA) in the Cerebrospinal Fluid (CSF) Detects Cytologically Occult Central Nervous System (CNS) Involvement in Aggressive Lymphomas. Blood. 134(Supplement_1). 2800–2800. 1 indexed citations
14.
Niroula, Rabin, et al.. (2019). Caplacizumab As Step-up Therapy in Refractory TTP Utilizing Adamts-13 Activity and Evidence of End-Organ Damage. Blood. 134(Supplement_1). 4909–4909. 1 indexed citations
15.
Şahin, İlyas & Rabin Niroula. (2019). Erythrophagocytosis on bone marrow found in severe autoimmune hemolytic anemia with reticulocytopenia. Blood. 134(21). 1877–1877. 2 indexed citations
16.
Şahin, İlyas, John L. Reagan, Rabin Niroula, & Joseph D. Sweeney. (2018). Refractoriness to red blood cell transfusion therapy due to hypersplenism. Transfusion. 58(11). 2513–2516. 6 indexed citations
17.
18.
Niroula, Rabin & James N. Butera. (2015). Genetics and diffuse large B-Cell lymphoma.. PubMed. 98(11). 23–6. 1 indexed citations
19.
Atreya, Alok, Tanuj Kanchan, Samata Nepal, & Rabin Niroula. (2015). EEG and psychological assessment in attempted hangings: A case of near-hanging from Nepal.. 2 indexed citations
20.
Chhabra, Lovely, et al.. (2013). Retrograde embolism from the descending thoracic aorta causing stroke: An underappreciated clinical condition. Indian Heart Journal. 65(3). 319–322. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Lidija Dokmanović Breakdown of academic impact, for papers by Takanobu Morishita Breakdown of academic impact, for papers by Waleed Sabry Breakdown of academic impact, for papers by Min‐Yuan Wu Breakdown of academic impact, for papers by Eiju Negoro Breakdown of academic impact, for papers by Manuela Rizzo Breakdown of academic impact, for papers by Wanling Sun Breakdown of academic impact, for papers by Amandeep Godara Breakdown of academic impact, for papers by Raoul Santiago Breakdown of academic impact, for papers by Amr Hanbali
Rankless by CCL
2026